Kamolika Roy1, Lesley C Pepin2, Marlie Philiossaint2, Natacha Lorius1, J Alex Becker2, Joseph J Locascio3, Dorene M Rentz1, Reisa A Sperling1, Keith A Johnson4, Gad A Marshall1. 1. Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 2. Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 3. Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 4. Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Abstract
BACKGROUND: Impairment in instrumental activities of daily living (IADL) begins as individuals with amnestic mild cognitive impairment (MCI) transition to Alzheimer's disease (AD) dementia. IADL impairment in AD dementia has been associated with inferior parietal, inferior temporal, and superior occipital hypometabolism using 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET). OBJECTIVE: To investigate the relationship between regional FDG metabolism and IADL in clinically normal (CN) elderly, MCI, and mild AD dementia subjects cross-sectionally and longitudinally. METHODS: One hundred and four CN, 203 MCI, and 95 AD dementia subjects from the Alzheimer's Disease Neuroimaging Initiative underwent clinical assessments every 6 to 12 months for up to three years and baseline FDG PET. The subjective, informant-based Functional Activities Questionnaire was used to assess IADL. General linear models and mixed effects models were used, covarying for demographics, cognition, and behavior. RESULTS: The cross-sectional analysis revealed middle frontal and orbitofrontal hypometabolism were significantly associated with greater IADL impairment. Additionally, the interaction of diagnosis with posterior cingulate and with parahippocampal hypometabolism showed a greater decline in IADL performance as metabolism decreased for the AD dementia relative to the MCI group, and the MCI group relative to the CN group. The longitudinal analysis showed that baseline middle frontal and posterior cingulate hypometabolism were significantly associated with greater rate of increase in IADL impairment over time. CONCLUSION: These results suggest that regional synaptic dysfunction, including the Alzheimer-typical medial parietal and less typical frontal regions, relates to daily functioning decline at baseline and over time across the early AD spectrum.
BACKGROUND: Impairment in instrumental activities of daily living (IADL) begins as individuals with amnestic mild cognitive impairment (MCI) transition to Alzheimer's disease (AD) dementia. IADL impairment in AD dementia has been associated with inferior parietal, inferior temporal, and superior occipital hypometabolism using 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET). OBJECTIVE: To investigate the relationship between regional FDG metabolism and IADL in clinically normal (CN) elderly, MCI, and mild AD dementia subjects cross-sectionally and longitudinally. METHODS: One hundred and four CN, 203 MCI, and 95 AD dementia subjects from the Alzheimer's Disease Neuroimaging Initiative underwent clinical assessments every 6 to 12 months for up to three years and baseline FDG PET. The subjective, informant-based Functional Activities Questionnaire was used to assess IADL. General linear models and mixed effects models were used, covarying for demographics, cognition, and behavior. RESULTS: The cross-sectional analysis revealed middle frontal and orbitofrontal hypometabolism were significantly associated with greater IADL impairment. Additionally, the interaction of diagnosis with posterior cingulate and with parahippocampal hypometabolism showed a greater decline in IADL performance as metabolism decreased for the AD dementia relative to the MCI group, and the MCI group relative to the CN group. The longitudinal analysis showed that baseline middle frontal and posterior cingulate hypometabolism were significantly associated with greater rate of increase in IADL impairment over time. CONCLUSION: These results suggest that regional synaptic dysfunction, including the Alzheimer-typical medial parietal and less typical frontal regions, relates to daily functioning decline at baseline and over time across the early AD spectrum.
Authors: M H Tabert; S M Albert; L Borukhova-Milov; Y Camacho; G Pelton; X Liu; Y Stern; D P Devanand Journal: Neurology Date: 2002-03-12 Impact factor: 9.910
Authors: Jill M Goldstein; Larry J Seidman; Nikos Makris; Todd Ahern; Liam M O'Brien; Verne S Caviness; David N Kennedy; Stephen V Faraone; Ming T Tsuang Journal: Biol Psychiatry Date: 2006-10-13 Impact factor: 13.382
Authors: Randy L Buckner; Abraham Z Snyder; Benjamin J Shannon; Gina LaRossa; Rimmon Sachs; Anthony F Fotenos; Yvette I Sheline; William E Klunk; Chester A Mathis; John C Morris; Mark A Mintun Journal: J Neurosci Date: 2005-08-24 Impact factor: 6.167
Authors: Patricia A Boyle; Paul F Malloy; Stephen Salloway; Deborah A Cahn-Weiner; Ronald Cohen; Jeffrey L Cummings Journal: Am J Geriatr Psychiatry Date: 2003 Mar-Apr Impact factor: 4.105
Authors: Maria Vassilaki; Jeremiah A Aakre; Walter K Kremers; Michelle M Mielke; Yonas E Geda; Mary M Machulda; David S Knopman; Preciosa M Coloma; Barbara Schauble; Prashanthi Vemuri; Val J Lowe; Clifford R Jack; Ronald C Petersen; Rosebud O Roberts Journal: J Am Geriatr Soc Date: 2018-11-21 Impact factor: 5.562
Authors: Gad A Marshall; Amy S Zoller; Kathleen E Kelly; Rebecca E Amariglio; Joseph J Locascio; Keith A Johnson; Reisa A Sperling; Dorene M Rentz Journal: Curr Alzheimer Res Date: 2014 Impact factor: 3.498
Authors: Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski Journal: Alzheimers Dement Date: 2017-03-22 Impact factor: 21.566
Authors: Amy S Zoller; Ildiko M Gaal; Christine A Royer; Joseph J Locascio; Rebecca E Amariglio; Deborah Blacker; Olivia I Okereke; Keith A Johnson; Reisa A Sperling; Dorene M Rentz; Gad A Marshall Journal: Curr Alzheimer Res Date: 2014 Impact factor: 3.498
Authors: Gad A Marshall; Jennifer R Gatchel; Nancy J Donovan; Martha C Muniz; Aaron P Schultz; J Alex Becker; Jasmeer P Chhatwal; Bernard J Hanseeuw; Kathryn V Papp; Rebecca E Amariglio; Dorene M Rentz; Reisa A Sperling; Keith A Johnson Journal: J Alzheimers Dis Date: 2019 Impact factor: 4.472
Authors: Bernard J Hanseeuw; Aaron P Schultz; Rebecca A Betensky; Reisa A Sperling; Keith A Johnson Journal: Alzheimers Dement Date: 2016-07-13 Impact factor: 21.566